BANGOR, WALES, UK / ACCESSWIRE / March 10, 2020 / Bangor University: Amazon rainforest could be gone within a lifetime Large ecosystems, such as the Amazon rainforest, will collapse and disappear alarmingly quickly, once a crucial tipping point is reached, according to calculations based on real-world data. Writing in Nature Comms (10.1038/s41467-020-15029-x), researchers from Bangor University, Southampton University and The...
Read more
TAMPA, FL / ACCESSWIRE / March 10, 2020 / Trxade Group, Inc. (NASDAQ:MEDS) an integrated drug procurement, delivery and healthcare platform announces the onset of a new membership service by its subsidiaries Bonum Health and DelivMeds. Effective immediately the companies' monthly subscription rate of $19.95 includes an option of three (3) premium visits per month as well as free prescription delivery service through its...
Read moreVANCOUVER, BC / ACCESSWIRE / March 9, 2020 / HemaGenetics Technologies Corp. (the "Company"), due to ongoing public market turmoil and business uncertainty, has cancelled the previously scheduled effective date of Tuesday, March 10, 2020, for the share distribution under the plan of arrangement with 1208616 B.C. Ltd. ("616BC"). The Company will provide another shareholder update and setting of a new effective date for the...
Read moreVANCOUVER, BC / ACCESSWIRE / March 5, 2020 / HemaGenetics Technologies Corp. (the "Company") is pleased to announce that it has set the effective date for Tuesday, March 10, 2020 (the "Effective Date") for the share distribution under the plan of arrangement with 1208616 B.C. Ltd. ("616BC"), which is the distribution date for the shareholders of the Company who would receive 8,502,104 common shares of 616BC. Upon...
Read more
VenoValve Patients Continue to Show Improvement at 6 Months and 1 Year IRVINE, CA / ACCESSWIRE / March 5, 2020 / Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that Dr. Jorge Hernando Ulloa, the Principal Investigator for HJLI's first-in-man VenoValve study in Colombia, presented new VenoValve data at the 32nd Annual Meeting of the American...
Read more
BOSTON, MA / ACCESSWIRE / March 5, 2020 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today announced that it will host a full-year 2019 investor call on Thursday, March 12, 2020 at 8:00 AM EDT to discuss financial results and provide a corporate update. To...
Read more
Update is to change a hyperlink within the release. Board changes and development partnership with DavosPharma also announced; DavosPharma will oversee the preparation of clinical supplies and regulatory clearances to advance PCLX-001 through development for Phase I clinical trials. EDMONTON, ALBERTA / ACCESSWIRE / March 4, 2020 / PACYLEX PHARMACEUTICALS INC. (Pacylex), a pre-clinical pharmaceutical company, announces it raised over...
Read more
AUSTIN, TX & CAMBRIDGE, MA / ACCESSWIRE / March 4, 2020 / Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases, today announced it will be presenting at the third annual LD Micro Virtual Conference on Wednesday, March 4 at 1:40 p.m. EST. Genprex's Chairman and Chief Executive...
Read more
$2.2M grant from NIH enables pivotal study MOUNTAIN VIEW, CA / ACCESSWIRE / March 3, 2020 / Materna Medical (Materna), a MedTech company developing products to help protect women's pelvic health, announced today they have formally initiated a pivotal study for their Materna Prep device. The National Institutes of Health (NIH) funded pivotal study will enroll around 200 patients over 24-months and is intended to support a De Novo...
Read more
ADR Ratio Change Total Voting Rights ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 2, 2020 / Midatech Pharma PLC (AIM:MTPH.L; NASDAQ:MTP) ("Midatech" or the "Company"), an R&D biotechnology company focused on delivering innovative oncology and rare disease products to patients, announces that all resolutions were passed at a general meeting of shareholders of the Company held earlier today. Consequently, with effect...
Read more
GOLDEN, CO / ACCESSWIRE / February 27, 2020 /Vitro Diagnostics, Inc. (OTCPK:VODG), dba Vitro Biopharma reports on a potential therapy of Coronavirus (COVID-19) infections by stem cell transplant. While this therapy is not a method to eradicate or cure Coronavirus, there is evidence to support the concept that infected patients may be more likely to combat and survive infection. First, stem cells resist viral attack by the expression of certain...
Read moreVANCOUVER, BC / ACCESSWIRE / February 27, 2020 / HemaGenetics Technologies Corp. (the "Company") is pleased to announce that it has set the share distribution record date for the Arrangement with 1208616 B.C. Ltd. as February 28, 2020, which is the record date for the shareholders of the Company who would receive 8,502,104 common shares of 1208616 B.C. Ltd. ("616BC") upon the effective (distribution and spin out) date of the...
Read more
Multidimensional Biomarkers Outperform Single Analyte Immunohistochemistry in Head and Neck Cancer SCOTTSDALE, AZ / ACCESSWIRE / February 27, 2020 / Cofactor Genomics, the company bridging the precision medicine gap with Predictive Immune Modeling, today announced preliminary results from a collaborative study with Washington University School of Medicine in St. Louis, which demonstrated the superior performance of the company's...
Read more
FRAMINGHAM, MA / ACCESSWIRE / February 27, 2020 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, announced today that the webcast replay from the presentation given by Jeffrey Eisenberg, Chief Executive Officer of Xenetic, at NobleCon16 -...
Read more
VANCOUVER, BC / ACCESSWIRE / February 26, 2020 / Mota Ventures Corp. (CSE:MOTA)(OTC:PEMTF)(FRANKFURT:1WZGR) ("Mota") and Stillcanna Inc. (STIL)(SCNNF)(A2PEWA) ("Stillcanna") are pleased to announce that they have entered into a letter of intent (the "Letter of Intent"), dated effective February 25, 2020, pursuant to which Mota proposes to acquire all of the outstanding share capital of Stillcanna (the "Proposed...
Read more
Updated VenoValve data will include 8 Patients at 180 days - including 1 Patient at 365 Days Post VenoValve Surgery IRVINE, CA / ACCESSWIRE / February 26, 2020 / Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that on Wednesday, March 4, 2020, Dr. Jorge Hernando Ulloa, the Principal Investigator for HJLI's first-in-man VenoValve study in...
Read more
- Dr. MacMichael brings over 35 years of experience in development and manufacture of therapeutic proteins, vaccines, and cell and gene therapies - - Dr. MacMichael to play key role in guiding cell therapy CMC to advance XCART™ Platform - FRAMINGHAM, MA / ACCESSWIRE / February 26, 2020 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing...
Read more
NES-ZIONA, ISRAEL and JUPITER, FL / ACCESSWIRE / February 25, 2020 / Dyadic International, Inc. (''Dyadic'') (NASDAQ:DYAI), a global biotechnology company announced today that they are joining the global fight against the coronavirus outbreak by collaborating with The Israel Institute for Biological Research ("IIBR"), a governmental research institute established to provide the State of Israel with scientific response to chemical and biological...
Read more
BOSTON, MA / ACCESSWIRE / February 25, 2020 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, today announced that members of the management team will participate in the following upcoming scientific and investor conferences: 6th Annual Immuno-Oncology 360°...
Read more
ANGLE AND BIOVIEW TO PRESENT COMBINED SOLUTION FOR CIRCULATING TUMOR CELL DETECTION AND ANALYSIS AT MOLECULAR MED TRI-CON 2020 IN SAN FRANCISCO, 4 MARCH 2020 GUILDFORD, SURREY / ACCESSWIRE / February 25, 2020 / ANGLE plc, (AIM:AGL)(OTCQX:ANPCY) a world leading liquid biopsy company, and BioView Ltd. (TASE:BIOV), a provider of automated cell imaging and analysis solutions, announced today that they will present results of their recent...
Read more
